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Kingella kingae had rarely been reported as a causative organism for corneal ulcer and had not been described before in vernal
keratoconjunctivitis (VKC). Generally regarded as commensals of respiratory tract particularly in young children, it had however
been isolated from the corneal ulcer scraping of both adult and children.We report a case of bacterial ulcer with isolation ofKingella
kingae from the corneal scraping in a young child with underlying VKC.
1. Introduction
Kingella kingae is a facultative anaerobic, nonmotile, and
fastidious 𝛽-hemolytic Gram-negative coccobacilli. It is an
oxidase-positive, yielding negative catalase organism that
is usually found as commensals of posterior pharynx and
mouth [1]. Patients with invasive Kingella kingae breach the
epithelium to enter the bloodstream and commonly pre-
sented with skeletal infection, bacteraemia, and endocarditis.
It had been identified as an emerging pathogen amongst
children, possibly due to better detection [2].
This organism had rarely been reported as a causative
organism for corneal ulcer. Based on PubMed literature
search, since 1992 until 2016, there were only 5 reported cases
of corneal ulcer associated with Kingella kingae [3–5]. There
was no previous report on patients with underlying vernal
keratoconjunctivitis (VKC). The first case of Kingella kingae
isolated from a corneal ulcer was reported by Mollee et al.
in 1992 in Australia [3]. We describe here a case of corneal
ulcer caused by Kingella kingae in a paediatric patient with
underlying VKC.
2. Case Report
A 4-year-old boy who is followed up for VKC presented to
the casualty clinic with right eye pain and refusal to open his
right eye for 2 days. His mother noted a whitish opacity over
his right eye on the day of presentation.
He had no previous history of local steroid injection for
his VKC and no previous episode of shield ulcer. On his
latest visit, there was compromised corneal epithelium with
presence of multiple punctate epithelial erosions. However,
there was no shield ulcer or corneal scar documented. His
usual topical treatment consists of olopatadine twice daily
and hydroxypropyl methylcellulose 6 hourly in both eyes.
Therewas nohistory of recent eye traumaor foreign body that
could cause corneal injury. He was not a contact lens wearer.
On examination, the right eye conjunctiva was hyper-
aemic with presence of active papillae over the eyelids.
There was presence of central corneal ulcer with fluffy
edge measuring 3.6 × 4.0mm associated with dense stromal
infiltrate (Figure 1). The anterior chamber showed intense
inflammation with fibrin and a streak of hypopyon. His
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Table 1: Reported cases of Kingella kingae corneal ulcer.
Number Author & year Age/gender Ocular and systemiccomorbidity Clinical findings Treatment Outcome
(1) Theo Mollee et al.,1992 11 months/male Nil Red eye, eye discharge
Gentamicin and
cephalothin Ulcer healed
(2)
Maria-Carmen
Munoz-Egea et al.,
2010
38 years/female Contact lens wearer
Painful red eye for 2
days
Mixed hyperaemia
with paracentral
corneal infiltrate
measuring 1 × 1mm
Moxifloxacin and
tobramycin Healed in 19 days
(3)
Maria-Carmen
Munoz-Egea et al.,
2012
45 years/male HIV positive Painful red eye for 2weeks
Vancomycin and
ceftazidime, then
changed to
gentamicin and
ciprofloxacin
Unknown. Loss to
follow-up
(4) Orli Megged et al.,2013 15 years/female
Soft contact lens
wearer
Painful red eye. Small
corneal ulcer with
grade 2 flare
Cefazoline,
gentamicin
Healed in 6 weeks
with faint scar and
no visual
impairment
(5) Orli Megged et al.,2014 18 years/female Nil
Painful red eye. Small
2.5mm corneal ulcer
at peripheral cornea
Cefazoline,
gentamicin
Healed completely
in 9 days
Figure 1: Kingella kingae corneal ulcer with fluffy edge and dense
stromal infiltrate.
right intraocular pressure was increased to 36-37mmHg in
contrast to 20mmHg over the left eye.
Corneal scraping was collected and sent to microbiology
laboratory for Gram staining and culture. The Gram stain
reviewed Gram-negative coccobacilli. Kingella kingae was
isolated from the corneal ulcer and detected by nucleic acid
amplification technique usingVITEK 2 SystemsVersion 07.01
with very good identification and 94% probability of Kingella
kingae.
He was admitted for intensive treatment and commenced
on topical moxifloxacin (0.5%) hourly and ceftazidime (5%)
hourly, along with topical intraocular pressure lowering
agents: timolol maleate twice daily and dorzolamide eight
hourly. The topical treatment for VKC was continued.
He showed good improvement with topical antimicrobial
therapy and was discharged after seven days of treatment
in the ward. Treatment was continued in tapering dosage
as outpatient basis with frequent regular follow-up. On
subsequent visit, his intraocular pressure normalized and his
intraocular pressure lowering agents was stopped. The ulcer
healed well with presence of residual central corneal scar.
3. Discussion
Kingella kingae was previously considered an organism that
rarely causes diseases [1]. However, this may be attributed
to the fastidious nature of the organism [6] which makes
it difficult to be isolated from the affected site. With the
advances of detection technique [7, 8], it has been increas-
ingly recognized as a pathogenic organism, particularly in
skeletal system infection, endocarditis, and bacteraemia [2].
Kingella kingae is generally regarded as a pathogenmainly
amongst children [2]. However, it may also affect a broad
range of age from babies to adult in cases of corneal ulcer
with the youngest reported age being 11months and the oldest
being 45 years [3–5].
VKC is an allergymediated disease that causes disruption
of the ocular surface. Clinical features include itching red
eye with giant papillae, Trantas dots, bulbar conjunctival
pigmentation, and mucous discharge. VKC may be further
complicated by development of corneal scar, shield ulcers,
microbial keratitis, limbal stem cell deficiencies, and com-
plications related to corticosteroid treatment such as cataract
and glaucoma [9]. Saboo et al. described that the prevalence
of microbial keratitis amongst patients with VKC is about
0.42% [9].
Table 1 summarizes published cases of corneal ulcer
patients with Kingella kingae infection. Contact lens usage
and human immunodeficiency virus (HIV) positive status
had been reported [4, 5]. Kingella kingae was isolated from
a corneal ulcer in an 11-month-old baby with no ocular or
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systemic comorbidity [3]. Another case described byMegged
et al. [5] in an 18-year-old teenager also had no other
predisposing factor that could compromise the state of cornea
or immune status.
Corneal ulcer caused byKingella kingae respondedwell to
topical antimicrobial therapy in all the reported cases [3–5].
The type of antimicrobial therapy used varies from aminogly-
cosides, cephalosporins, fluoroquinolones, and glycopeptide
antibiotics. However, the patient with positive HIV infection
was lost to follow-up, without definitive final outcome status
[4].
Our patient has a compromised state of cornea evidenced
by presence of multiple punctate epithelial erosions. The
preexisting VKC resulted in unhealthy ocular surface, which
may serve as a precipitating factor. The most probable
mechanism by which Kingella kingae causes corneal ulcer is
through direct spread of the organism from the mouth to
contaminate hands and frequent rubbing of the itchy eye. It
may also be facilitated by the compromised corneal status.
In VKC individuals, the dendritic cells which are impor-
tant in initiating immune response were of a more mature
phenotype, but less potent T-cell stimulators compared to
their normal counterparts [10].Thismay contribute to abnor-
mal inflammatory response and increase the susceptibility to
infection [10]. Punctate epithelial erosion which is a feature
of VKC and indicative of desiccating stress on the cornea
surface causes further disruption of corneal barrier function
via T helper- (Th-) 1 and Th-17 response and involvement of
interleukin- (IL-) 17 [11].
Although in most cases Kingella kingae infection usually
runs a benign clinical course and in most cases of corneal
ulcer, it healed well with antimicrobial therapy, in this case,
presence of residual central corneal scar may complicate the
condition with amblyopia. Thus, early detection and prompt
treatment are necessary to prevent further sequelae from
keratitis.
4. Conclusion
Kingella kingae is an emerging pathogen in paediatric age
group that can rarely cause corneal ulcer. It generally
responds well to topical antimicrobial treatment. This case
report and literature review add to the current knowledge on
Kingella kingae related corneal ulcer in paediatric population.
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